You just read:

New Data Presented at European Crohn's and Colitis Organisation (ECCO) Scientific Meeting on Efficacy of Long-Term Vedolizumab Treatment

News provided by

Takeda Pharmaceutical Company Limited

19 Mar, 2016, 08:19 GMT